BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30837409)

  • 1. [Research advance in gastric neuroendocrine tumors].
    Wang Z; Gu Y; Ren Y; Wang K; Ma Z; Jiao Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Jan; 44(1):92-99. PubMed ID: 30837409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?
    Cavalcoli F; Zilli A; Conte D; Ciafardini C; Massironi S
    Scand J Gastroenterol; 2015; 50(11):1397-403. PubMed ID: 26059834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric Neuroendocrine Tumors (Carcinoids).
    Gluckman CR; Metz DC
    Curr Gastroenterol Rep; 2019 Mar; 21(4):13. PubMed ID: 30868284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Old and New Gut Hormone, Gastrin and Acid Suppressive Therapy.
    Haruma K; Kamada T; Manabe N; Suehiro M; Kawamoto H; Shiotani A
    Digestion; 2018; 97(4):340-344. PubMed ID: 29587283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms.
    Ko Y; Tang J; Sanagapalli S; Kim BS; Leong RW
    Expert Opin Drug Saf; 2016 Jan; 15(1):53-63. PubMed ID: 26560097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases].
    Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypergastrinemia as a cause of chromogranin a increase in blood in patients suspected to have neuroendocrine tumor.
    Kleveland O; Syversen U; Slørdahl K; Waldum HL
    Digestion; 2001; 64(2):71-4. PubMed ID: 11684818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of endoscopic resection for type I gastric neuroendocrine tumors.
    Uygun A; Kadayifci A; Polat Z; Yilmaz K; Gunal A; Demir H; Bagci S
    J Surg Oncol; 2014 Feb; 109(2):71-4. PubMed ID: 24165913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term high-dose proton pump inhibitor administration to Helicobacter pylori-infected Mongolian gerbils enhances neuroendocrine tumor development in the glandular stomach.
    Tsukamoto H; Mizoshita T; Sasaki M; Mizushima T; Tanida S; Ozeki K; Hirata Y; Shimura T; Kataoka H; Kamiya T; Nojiri S; Tsukamoto T; Tatematsu M; Joh T
    Asian Pac J Cancer Prev; 2011; 12(4):1049-54. PubMed ID: 21790250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric NET Subtypes: Do We Need An Additional One?
    Lock G; Oelckers M; Clauditz TS; Schrader J
    Z Gastroenterol; 2021 Mar; 59(3):255-258. PubMed ID: 33506449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A knockin mouse model for human ATP4aR703C mutation identified in familial gastric neuroendocrine tumors recapitulates the premalignant condition of the human disease and suggests new therapeutic strategies.
    Calvete O; Varro A; Pritchard DM; Barroso A; Oteo M; Morcillo MÁ; Vargiu P; Dodd S; Garcia M; Reyes J; Ortega S; Benitez J
    Dis Model Mech; 2016 Sep; 9(9):975-84. PubMed ID: 27491072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine Tumors of the Stomach.
    Corey B; Chen H
    Surg Clin North Am; 2017 Apr; 97(2):333-343. PubMed ID: 28325190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gastric neuroendocrine tumors: clinical, endoscopic presentation and alternatives of treatment].
    Lazarte R; Poniachik J; Smok G; Contreras J; Gutiérrez L; Csendes A
    Rev Med Chil; 2002 Sep; 130(9):985-92. PubMed ID: 12434645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of Gastric NETs: Role of Gastrin and Menin.
    Sundaresan S; Kang AJ; Merchant JL
    Curr Gastroenterol Rep; 2017 Jul; 19(7):32. PubMed ID: 28608155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study.
    Campana D; Ravizza D; Ferolla P; Faggiano A; Grimaldi F; Albertelli M; Berretti D; Castellani D; Cacciari G; Fazio N; Colao A; Ferone D; Tomassetti P
    Endocrine; 2016 Jan; 51(1):131-9. PubMed ID: 25814125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent gastric neuroendocrine tumors treated with total gastrectomy.
    Jung M; Kim JW; Jang JY; Chang YW; Park SH; Kim YH; Kim YW
    World J Gastroenterol; 2015 Dec; 21(46):13195-200. PubMed ID: 26675502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.
    Anjiki H; Mukaisho KI; Kadomoto Y; Doi H; Yoshikawa K; Nakayama T; Vo DT; Hattori T; Sugihara H
    Clin J Gastroenterol; 2017 Apr; 10(2):128-136. PubMed ID: 28160247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric neuroendocrine tumors.
    Delle Fave G; Capurso G; Annibale B; Panzuto F
    Neuroendocrinology; 2004; 80 Suppl 1():16-9. PubMed ID: 15477710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.
    Lundell L; Vieth M; Gibson F; Nagy P; Kahrilas PJ
    Aliment Pharmacol Ther; 2015 Sep; 42(6):649-63. PubMed ID: 26177572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gastric carcinoid in chronic atrophic gastritis with hypergastrinemia].
    Höring E; Egner E; von Gaisberg U
    Leber Magen Darm; 1991 Mar; 21(2):83-6. PubMed ID: 2038230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.